Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia

Novel T719P AβPP Mutation Unbalances the Relative Proportion of Amyloid-β Peptides

(2017) Roberta Ghidoni et al.   JOURNAL OF ALZHEIMERS DISEASE

Novel AβIsoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment

(2012) Erik Portelius et al.   CURRENT PHARMACEUTICAL DESIGN

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

APP processing in Alzheimer's disease

(2011) Yun-wu Zhang et al.   Molecular Brain

Alzheimer's CSF markers in older schizophrenia patients

(2010) Giovanni B. Frisoni et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS

(2010) Valentina Albertini et al.   Proteomics Clinical Applications

In Vivo Neuropathology of Cortical Changes in Elderly Persons with Schizophrenia

(2009) Giovanni B. Frisoni et al.   BIOLOGICAL PSYCHIATRY